Pfizer jab 97% effective against symptomatic Covid: study

An earlier real world study had showed effectiveness at preventing symptomatic disease at 94 percent and asymptomatic illness at 92 percent.

AFP

March 11, 2021 / 18:21 IST

Pfizer-Biontech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent.

Pfizer-Biontech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real world evidence published Thursday by pharma companies.

Using data from January 17 to March 6 from Israel's national vaccination campaign, Pfizer-Biontech found that prevention against asymptomatic disease also reached 94 percent.

An earlier real world study had showed effectiveness at preventing symptomatic disease at 94 percent and asymptomatic illness at 92 percent.

AFP

first published: Mar 11, 2021 06:21 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347